These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Electropharmacological effects of antiarrhythmic drugs on atrial fibrillation termination. Part II: New insights into the electrophysiological mechanisms of atrial fibrillation termination. Calò L; Sciarra L; Lamberti F; Loricchio ML; Castro A; Bianconi L; Pandozi C; Gaita F; Santini M Ital Heart J; 2003 Jul; 4(7):442-7. PubMed ID: 14558294 [TBL] [Abstract][Full Text] [Related]
8. Conduction gap across mitral isthmus line. Miyazaki S; Shah AJ; Scherr D; Haïssaguerre M J Cardiovasc Electrophysiol; 2012 May; 23(5):562-3. PubMed ID: 21806696 [No Abstract] [Full Text] [Related]
9. Critical review and commentary by Drs. Allessie and Schotten. Po SS Heart Rhythm; 2006 Aug; 3(8):990-1; author reply 991. PubMed ID: 16876757 [No Abstract] [Full Text] [Related]
10. Amiodarone and dronedarone: the worker bee and the drone? Franz MR; Singh SN Heart Rhythm; 2010 Sep; 7(9):1280-1. PubMed ID: 20620232 [No Abstract] [Full Text] [Related]
11. Ranolazine exerts potent effects on atrial electrical properties and abbreviates atrial fibrillation duration in the intact porcine heart. Kumar K; Nearing BD; Carvas M; Nascimento BC; Acar M; Belardinelli L; Verrier RL J Cardiovasc Electrophysiol; 2009 Jul; 20(7):796-802. PubMed ID: 19298570 [TBL] [Abstract][Full Text] [Related]
12. Temporal patterns of progression and regression of electrical and mechanical remodeling of the atrium. Kinebuchi O; Mitamura H; Shiroshita-Takeshita A; Kurita Y; Ohashi N; Tanimoto K; Fukuda Y; Ieda M; Sato T; Hara M; Takatsuki S; Ogawa S Int J Cardiol; 2005 Jan; 98(1):91-8. PubMed ID: 15676172 [TBL] [Abstract][Full Text] [Related]
13. Pulmonary veins in the substrate for atrial fibrillation: the "venous wave" hypothesis. Haïssaguerre M; Sanders P; Hocini M; Jaïs P; Clémenty J J Am Coll Cardiol; 2004 Jun; 43(12):2290-2. PubMed ID: 15193695 [No Abstract] [Full Text] [Related]
14. Hypertension and atrial fibrillation: evidence of progressive atrial remodeling with electrostructural correlate in a conscious chronically instrumented ovine model. Lau DH; Mackenzie L; Kelly DJ; Psaltis PJ; Brooks AG; Worthington M; Rajendram A; Kelly DR; Zhang Y; Kuklik P; Nelson AJ; Wong CX; Worthley SG; Rao M; Faull RJ; Edwards J; Saint DA; Sanders P Heart Rhythm; 2010 Sep; 7(9):1282-90. PubMed ID: 20466075 [TBL] [Abstract][Full Text] [Related]
15. Interatrial conduction in the mechanisms of atrial fibrillation: from anatomy to cardiac signals and new treatment modalities. Platonov PG Europace; 2007 Nov; 9 Suppl 6():vi10-6. PubMed ID: 17959684 [TBL] [Abstract][Full Text] [Related]
16. Left atrial pacemaker dominance after catheter ablation of atrial fibrillation. Sanders P; Scavée C; Jaïs P; Haïssaguerre M J Cardiovasc Electrophysiol; 2004 Nov; 15(11):1324-7. PubMed ID: 15574186 [TBL] [Abstract][Full Text] [Related]
17. Is atrial remodeling a viable target for prevention of atrial fibrillation recurrence? Nattel S J Cardiovasc Electrophysiol; 2004 Aug; 15(8):885-6. PubMed ID: 15333079 [No Abstract] [Full Text] [Related]
18. 5-hydroxytryptamine and atrial fibrillation: how significant is this piece in the puzzle? Yusuf S; Al-Saady N; Camm AJ J Cardiovasc Electrophysiol; 2003 Feb; 14(2):209-14. PubMed ID: 12693508 [TBL] [Abstract][Full Text] [Related]